RT Journal Article
SR Electronic
T1 The global distribution of COVID-19 vaccine: The role of macro-socioeconomics measures
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.09.21251436
DO 10.1101/2021.02.09.21251436
A1 Roghani, Ali
A1 Panahi, Samin
YR 2021
UL http://medrxiv.org/content/early/2021/02/12/2021.02.09.21251436.abstract
AB Since coronavirus disease 2019 (covid-19) has continued to spread globally, many countries have progressed clinical trials and started vaccinations at the end of December 2020. This report aims to analyze the association of COVID-19 vaccine distribution and two macro-socioeconomics measures, including human development index (HDI) and Gross domestic product (GDP), among 25 countries till the first week of February 2021. Our results indicate that a higher GDP per Capita is positively associated with higher COVID-19 vaccine distribution. However, UAE and Israel have more successful vaccine distribution outcomes regardless of their GDP. In addition, the result shows HDI does not have a significant relationship with vaccine distribution. Although these macro-socioeconomic measures may be counted as a vital indicator for vaccine distribution, other factors may play roles in vaccine distribution, including well-developed health infrastructure, a centralized political system, and population size.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeshttps://ourworldindata.org/coronavirus https://ourworldindata.org/coronavirus